1. Cost-Effectiveness Guidelines

   • Peter Gorham

   Guest Editorial 25 November 2012 Pages: 369 - 373

2. The Economics of Orphan Drug Policy in the US

   • John W. Peabody
   • Allen Ruby
   • Peter Cannon

   Leading Article 25 November 2012 Pages: 374 - 384

3. Cost Effectiveness of Antituberculosis Interventions

   • Adauto Castelo
   • Pedro A. Mathiasi
   • Michael Drummond

   Review Article 25 November 2012 Pages: 385 - 399

4. The Economic Effects of Introducing Vigabatrin, a New Antiepileptic Medication

   • Daniel Reinharz
   • Wendy Kennedy
   • François Champagne

   Original Research Article 25 November 2012 Pages: 400 - 409

5. The Cost Effectiveness of Helicobacter pylori Eradication versus Maintenance and Episodic Treatment in Duodenal Ulcer Patients in Sweden

   • Peter Unge
   • Bengt Jönsson
   • Nils-Olov Stålhammar

   Original Research Article 25 November 2012 Pages: 410 - 427

6. Alteplase

   • Lee B. Barradell
   • Karen L. Goa

   Pharmacoeconomic Drug Evaluation 25 November 2012 Pages: 428 - 459

7. Glossary

   News 25 November 2012 Pages: 460 - 463